Clinical Trial Update: Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD [Phase 1]

View source ↗

Summary

Phase 1 trial update of a vaccine therapy for organ transplant candidates at risk for post-transplant lymphoproliferative disorder (PTLD); study status terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorder

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lymphoproliferative Disorder | Phase 1 | Status: TERMINATED | Results posted: 2019-02-26